Geneva Advisors’s NASPERS LTD NPSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-14,830
Closed -$257K 822
2017
Q1
$257K Sell
14,830
-1,045
-7% -$18.1K ﹤0.01% 631
2016
Q4
$232K Sell
15,875
-785
-5% -$11.5K ﹤0.01% 645
2016
Q3
$290K Sell
16,660
-190
-1% -$3.31K 0.01% 585
2016
Q2
$258K Sell
16,850
-11,490
-41% -$176K 0.01% 575
2016
Q1
$397K Buy
28,340
+25,963
+1,092% +$364K 0.01% 479
2015
Q4
$324K Sell
2,377
-55
-2% -$7.5K 0.01% 486
2015
Q3
$304K Sell
2,432
-895
-27% -$112K 0.01% 478
2015
Q2
$518K Sell
3,327
-218
-6% -$33.9K 0.01% 421
2015
Q1
$547K Buy
3,545
+1,265
+55% +$195K 0.01% 398
2014
Q4
$296K Buy
+2,280
New +$296K 0.01% 513

Other funds holding NPSN

Geneva Advisors's NPSN Position: Q2 2017 in Review

Geneva Advisors sold out of NASPERS LTD (NPSN) in Q2 2017, closing a stake of 14,830 shares — an estimated $257K sold.

Geneva Advisors first reported a position in NPSN in Q4 2014 and held it in 10 quarters. The position peaked at $547K in Q1 2015. 11 funds tracked by Wall St. Rank hold NPSN as of Q2 2017.

  • Geneva Advisors reported no remaining NASPERS LTD position as of Q2 2017 after selling out during the quarter.
  • Geneva Advisors sold 14,830 NASPERS LTD shares in Q2 2017, an estimated $257K.
  • Geneva Advisors first reported a position in NASPERS LTD in Q4 2014 and held it in 10 quarters.
  • Geneva Advisors's NASPERS LTD position peaked at $547K in Q1 2015.
  • 11 funds tracked by Wall St. Rank held NASPERS LTD as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.